
Real‐world use of dupilumab for 53 patients with atopic dermatitis in Japan
Author(s) -
Matsutani Masako,
Imai Yasutomo,
Inoue Yukako,
Hosotani Yuka,
Kusakabe Minori,
Natsuaki Masaru,
Yamanishi Kiyofumi
Publication year - 2020
Publication title -
journal of cutaneous immunology and allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.127
H-Index - 1
ISSN - 2574-4593
DOI - 10.1002/cia2.12099
Subject(s) - dupilumab , atopic dermatitis , dermatology , medicine
Dupilumab was effective for 53 patients with moderate‐to‐severe AD in our daily practice. TARC reduction, however, did not necessarily reflect improved AD.